These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fumaric acid esters for psoriasis: a systematic review. Smith D Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164 [TBL] [Abstract][Full Text] [Related]
4. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. Mrowietz U; Barker J; Boehncke WH; Iversen L; Kirby B; Naldi L; Reich K; Tanew A; van de Kerkhof PCM; Warren RB J Eur Acad Dermatol Venereol; 2018 Oct; 32 Suppl 3():3-14. PubMed ID: 30238510 [TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Mrowietz U; Christophers E; Altmeyer P Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799 [TBL] [Abstract][Full Text] [Related]
6. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Balasubramaniam P; Stevenson O; Berth-Jones J Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371 [TBL] [Abstract][Full Text] [Related]
7. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Harries MJ; Chalmers RJ; Griffiths CE Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST). Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244 [TBL] [Abstract][Full Text] [Related]
10. Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS). Thaçi D; Pinter A; Sebastian M; Termeer C; Sticherling M; Gerdes S; Wegner S; Krampe S; Bartz H; Rausch C; Mensch A; Eyerich K Br J Dermatol; 2020 Aug; 183(2):265-275. PubMed ID: 31705526 [TBL] [Abstract][Full Text] [Related]
11. Use of fumaric acid esters in psoriasis. Roll A; Reich K; Boer A Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929 [TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data. Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575 [TBL] [Abstract][Full Text] [Related]
13. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study. Dickel H; Bruckner T; Altmeyer P J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands. Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fumaric acid esters in young patients aged 10-17 years with moderate-to-severe plaque psoriasis: a randomized, double-blinded, placebo-controlled trial. Hamm H; Wilsmann-Theis D; Tsianakas A; Gambichler T; Taipale K; Lauterbach J; Freudensprung U; Makepeace C; Br J Dermatol; 2021 Jul; 185(1):62-73. PubMed ID: 33332574 [TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study. Tzaneva S; Geroldinger A; Trattner H; Tanew A Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862 [TBL] [Abstract][Full Text] [Related]
17. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care. Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255 [TBL] [Abstract][Full Text] [Related]
19. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE). Pinter A; Hoffmann M; Reich K; Augustin M; Kaplan K; Gudjónsdóttir SD; Delvin T; Mrowietz U; J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):701-711. PubMed ID: 32939860 [TBL] [Abstract][Full Text] [Related]
20. Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice. Termeer C; Reinhold U; Dirschka T; von Kiedrowski R; Kurzen H J Dermatolog Treat; 2021 Sep; 32(6):610-616. PubMed ID: 31682772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]